Bioplastics produced from microbial source are promising green alternatives to 23 traditional petrochemical-derived plastics. Nonnatural straight-chain amino acids, 24 especially 5-aminovalerate, 6-aminocaproate and 7-aminoheptanoate are potential 25 monomers for the synthesis of polymeric bioplastics as their primary amine and 26 carboxylic acid are ideal functional groups for polymerization. Previous pathways for 27 5-aminovalerate and 6-aminocaproate biosynthesis in microorganisms are derived from 28 L-lysine catabolism and citric acid cycle, respectively. Here, we show the construction 29 of an artificial iterative carbon-chain-extension cycle in Escherichia coli for 30 simultaneous production of a series of nonnatural amino acids with varying chain length. 31 Overexpression of L-lysine α-oxidase in E. coli yields 2-keto-6-aminocaproate as a 32 non-native substrate for the artificial iterative carbon-chain-extension cycle. The chain-33 extended α-ketoacid is subsequently decarboxylated and oxidized by an α-ketoacid 34 decarboxylase and an aldehyde dehydrogenase, respectively, to yield the nonnatural 35 straight-chain amino acid products. The engineered system demonstrated simultaneous 36 in vitro production of 99.16 mg/L of 5-aminovalerate, 46.96 mg/L of 6-aminocaproate 37 and 4.78 mg/L of 7-aminoheptanoate after 8 hours of enzyme catalysis starting from 2-38 keto-6-aminocaproate as the substrate. Furthermore, simultaneous production of 2.15 39 g/L of 5-aminovalerate, 24.12 mg/L of 6-aminocaproate and 4.74 mg/L of 7-40 aminoheptanoate was achieved in engineered E. coli. This work illustrates a promising 41 metabolic-engineering strategy to access other medium-chain organic acids with -NH2, 42 -SCH3, -SOCH3, -SH, -COOH, -COH, or -OH functional groups through carbon-chain-43 elongation chemistry.
Introduction

61
Microbial polyimide bioplastics present a class of green materials with broad 62 applications in many downstream industries, and can potentially replace the traditional BL21(DE3) was transformed with the plasmid pIVC03 or pIVC04 and pETaRKP, 159 resulting in strain CJ03 or CJ04. 160 2.2 Fermentation procedures 161 The fermentation media were developed for evaluating strain's potential for 162 NNSCAAs production. The medium was supplemented by 10 g/L NaCl, 10 g/L 163 tryptone, 5 g/L yeast extract, 1.0 mΜ MgSO4, 0.5 mM thiamine diphosphate (ThDP) 164 (Chen et al., 2017) . For NNSCAAs production, a single colony of the desired strain was 165 cultivated for 12 h at 37 °C and 250 RPM in 2 mL LB medium supplemented with 166 appropriate antibiotics. This starter culture were then transferred into 40 mL of 167 fermentation medium supplemented with appropriate antibiotics, 1.0 mM MgSO4 and 168 0.5 mM ThDP at 37 °C with 250 RPM orbital shaking at a starting optical density at 169 600 nm (OD600) of 0.1 in a 250 mL flask. After an OD600 of 0.6 has been reached, 0.5 170 mM of IPTG and 5 g/L of L-lysine were added. Flasks were then incubated at 30 °C . To measure the rate of the conversion of L-lysine into 6ACA by purified enzyme, 213 an assay mixture was established, which contained 800 μL of 50 mM KPB (pH 8.0), 214 2.5 mM L-lysine, 2.0 mM acetyl-CoA, 0.5 mM ThDP, 1.0 mM NAD + , 1.0 mM TCEP. 215 All assays were started with the addition of the different purified enzyme dosage and 216 incubating at 37 °C. 400 μL samples were withdrawn at designated time points and 217 inactivated at 75 °C for 10 min, and then centrifuged at 10000 RPM for 10 min to 218 remove cells for further metabolite analysis.
219
Analytical methods
220
The optical density of the various E. coli cultures was detected using a UV/visible 221 spectrophotometer (Ultrospec TM 2100 pro, GE Healthcare, UK). The quantification 222 of L-lysine, 5AVA, 6ACA and 7AHA were conducted by high performance liquid 223 chromatography (HPLC) using a 1260 system (Agilent Co., Ltd, CA, USA) with an 224 Agilent Eclipse XDB-C18 column (4.6 mm × 150 mm × 5 μm). For detection of L-225 lysine, 5AVA, 6ACA and 7AHA, 360 μL of culture centrifuged was derived with phenyl 226 isothiocyanate (PITC) (Cheng et al., 2018b; Zheng et al., 2015) . The operating 227 conditions were performed as 1.0 mL/min, column temperature 40 °C, wavelength 254 nm and analysis time 55 min. The gradient program was shown in Table S3 . For liquid 229 chromatography-mass spectrometry (LC-MS) identification of 5AVA, 6ACA and 230 7AHA, exact mass spectra were explored with a Bruker micrOTOF-Q II mass 231 spectrometer using the time of flight (TOF) technique, equipped with an ESI source 232 operating in negative mode (Burker Co., Ltd, USA). The product was verified by LC-233 MS (Fig. 3) . The approximate retention times of 5AVA, 6ACA, 7-aminoheptanoate 234 (7AHA) and L-lysine were 7.2 min, 9.4 min, 11.8 min and 25.6 min, respectively ( respectively, which were as the same as that of the 5AVA, 6ACA and 7AHA standards. The activities of various LeuA mutants (LeuA*) were shown in Fig. 2 . LeuA 251 exhibited low activity toward 2-keto-6-aminocaproate, whereas LeuA mutations 252 (H97A/G462D, H97G/G462D, H97L/G462D, S139G/G462D and S139I/G462D) 253 displayed higher activities. The LeuA H97L/S139G/G462D (LeuA # ) showed highest 254 activity shown in reported that the LeuA G462D mutant displays a low Kcat of 0.018 s -1 for (S)-2-keto-3-271 methylvalerate (Zhang et al., 2008) . However, the LeuA S139G/G462D mutant exhibits 272 a much higher Kcat of 0.12 s -1 for (S)-2-keto-3-methylvalerate. We therefore introduced 273 an additional mutations at His97 in LeuA # . Interestingly, LeuA # shows significantly 274 improved Kcat of 1.32 s -1 for 2-keto-6-aminocaproate shown in Table 2 . PadA was determined as 1:20:4:2:2:5:2 in this artificial iterative pathway, which was 349 inferred from the titration studies, as seen in Fig. 4 . 
371
In this work, we utilize the L-lysine-derivative 2-keto-6-aminocaproate as substrate for LeuA # BCD, therefore broadening the known substrate profile to include terminal-373 amino-group-containing α-ketoacids. Metabolic engineering of 6ACA production was 374 previously attempted in the strain eAKP-744 (Turk et al., 2016) . However, the reported 375 strategy was bottlenecked at the transamination step (Turk et al., 2016; Zhang et al., 376 2010). The production of 6ACA in the artificial iterative cycle developed in our study 377 circumvents the transamination step, therefore greatly improves the efficiency of the 378 whole process. We anticipate that the efficiency of this NNSCAA biosynthetic pathway 379 can be further improved by optimizing various components of the system. carbonyl (Benjamin and Collins, 1973; Cherest et al., 1968; Marcheschi et al., 2012) . 385 However, previous studies were based on α-ketoacids substrates without R groups and 386 the reactions were not iterative. Quantum mechanical calculation predicts that different 387 R groups containing -NH2, -SCH3, -SOCH3, -SH, -COOH, -COH or -OH would not janaschii is analogous to leuA in E. coli (Howell et al., 2000) . It is reported that the R 391 group of AksA includes -COOH. α-Ketoglutarate could be converted into α-392 ketoglutarate, α-ketoglutarate and α-ketoglutarate one after another in methanoarchaea 393 by overexpressing AksADEF (Howell et al., 2000; Howell et al., 1998) . While R group 394 of LeuA expected here is -NH2, the sequence identity between LeuA and AksA is 42%, 395 as seen in Fig. S4 . Several key residues at the LeuA active site have been verified to 396 play essential role in controlling the pocket size and hence substrate specifictity, in particular, H97, S139 and G462 shown in Fig. S2 (Chen et al., 2017; Xiong et al., 2012) .
398
The natural substrates of LeuA are 2-ketoisovalerate and 2-ketobutyrate (Shen and Liao, 399 2008). In this study, our engineered E. coli strain could use 2-keto-6-aminocaproate as 400 the alternative substrate to simultaneously produce 5AVA, 6ACA and 7AHA from L-401 lysine with a titer of total at 2.18 g/L, as seen in Fig. 7 . reaction, which may be further improved by directed evolution approach in the future.
413
Our success in metabolic engineering the production of 6-aminocaproate and other 414 NNSCAAs via the artificial iterative carbon-chain-extension cycle suggests that similar 415 strategies could be developed to produce other medium-chain-length acids with -NH2,
416
-SCH3, -SOCH3, -SH, -COOH, -COH or -OH functional groups. 
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599 Table 1 Purification of L-lysine α oxidase (RaiP) from Scomber japonicas and α-isopropylmalate synthase mutant LeuA # (LeuA with H97L/S139G/G462D mutations) expressed in E. coli.
Enzyme
Step Data are presented as means ± STDV calculated from at least three replicates. 50 μL of a fresh 3.0 mM solution of DTNB in 50 mM KPB was added, and the yellow color product was determined at 412 nm. Fig. 1 6 . Biosynthesis of NNSCAAs achieved via an artificial iterative carbon-chainextension cycle. A: Iterative carbon-chain-extension cycle reactions for NNSCAAs production from L-lysine were carried out using seven purified enzymes mixed together (1:20:4:2:2:5:2 based on purified protein quantification) with 1.0 mM MgCl2, 1.0 mM TCEP, 50 mM KPB, and coenzymes (ThDP, NAD + ). These purified enzymes individually contained RaiP, LeuA # , LeuB, LeuC, LeuD, KivD and PadA selectively overexpressed at 20 °C . B: RCCEC reactions for NNSCAAs production from L-lysine were carried out using seven crude lysates mixed together (1:20:4:2:2:5:2 based on total protein quantification) with 1.0 mM MgCl2, 1.0 mM TCEP, 50 mM KPB, and coenzymes (ThDP, NAD + ). These lysates individually contained RaiP, LeuA # , LeuB, LeuC, LeuD, KivD and PadA selectively overexpressed at 20 °C . NNSCAAs, Nonnatural straight chain amino acids. 5AVA, 5-Aminovalerate. 6ACA, 6-Aminocaproate. 7AHA, 7-Aminoheptanoate. All experiments were performed a minimum of three independent sets. All error bars represent standard deviations with n ≥ 3 independent reactions. Fig. 7 . NNSCAAs synthesis by engineered strain CJ04 in 250 mL flask. The cells were grown in 40 mL LB supplemented with 100 μg/mL ampicillin, 50 μg/mL kanamycin, 0.5 mM of IPTG, 5 g/L L-lysine, 1.0 mM MgSO4 and 0.5 mM ThDP at 37 °C with 250 RPM orbital shaking. Strain CJ04 is strain BL21(DE3) plus plasmids pIVC4 and pET21aRKP. NNSCAAs, Nonnatural straight chain amino acids. 5AVA, 5-Aminovalerate. 6ACA, 6-Aminocaproate. 7AHA, 7-Aminoheptanoate. All experiments were performed a minimum of three independent sets. All error bars represent standard deviations with n ≥ 3 independent reactions. 
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